DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present a business and development update on the Company’s lymphatic-focused technologies on Tuesday, February 15, 2011 at 11:30AM EST in the Basildon Room of the Waldorf Astoria Hotel in New York, NY, during the 13th Annual BIO CEO & Investor Conference.
